Johnson & Johnson (JNJ)

159.38
NYSE
Prev Close 157.09
Day Low/High 157.59 / 159.67
52 Wk Low/High 147.69 / 179.92
Exchange NYSE
Shares Outstanding 2632.60B
Market Cap 413.55B
P/E Ratio 28.74
Div & Yield N.A. (N.A)
Economic Growth? Trading Volume, OPEC+ Production, Vaccine Booster

Economic Growth? Trading Volume, OPEC+ Production, Vaccine Booster

These guys are aware that the U.S. was energy independent less than a year and a half ago, right?

Bond Yields, Infrastructure Bill, Job Creation, Earnings, Vaccine Booster Shots

Bond Yields, Infrastructure Bill, Job Creation, Earnings, Vaccine Booster Shots

One thing we know is that the current wave of the pandemic just seems to be getting worse.

Wednesday's Woes, Market Blame Game, Robinhood Goes Bananas, Scary Delta Math

Wednesday's Woes, Market Blame Game, Robinhood Goes Bananas, Scary Delta Math

Imagine if the SEC did not prohibit underwriters from lending out shares to short-sellers for 30 days after an IPO?

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.

Johnson & Johnson

Break in! sold off just now on this tweet: *FDA EXPECTED TO ANNOUNCE NEW WARNING ON J&J COVID VACCINE: WAPO This should help with the vaccine uptake — zerohedge (@zerohedge) July 12, 2021

Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game

Jim Cramer: I Warned You That Betting Against Science Is a Mug's Game

And I was right, and the cynics were wrong. Here's why that matters more than ever now.

The Johnson & Johnson Charts Are Healthy Enough for Further Gains

The Johnson & Johnson Charts Are Healthy Enough for Further Gains

Here's where traders could probe the long side of JNJ.

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.

A Mild and Mixed Market Favors Speculative Small-Caps

A Mild and Mixed Market Favors Speculative Small-Caps

Probably the best news right now is that individual stock picking has improved.

This Dividend Aristocrat Should Put Your Portfolio on the Mend

This Dividend Aristocrat Should Put Your Portfolio on the Mend

High-quality drugmaker AbbVie has several promising products aside from Humira and the market has priced the stock at a bargain.

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.

Best Stocks With DRIP Plans Right Now

Best Stocks With DRIP Plans Right Now

These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

ARCT's IP is incredibly valuable, and may in fact be invaluable.

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.

Jim Cramer: Secular Growth Is What Lam Research Is All About

Jim Cramer: Secular Growth Is What Lam Research Is All About

When you hear about chip shortage you need to think of Lam. The world needs Lam to add to capacity as fast as possible.

Get Alpha From Delta

Get Alpha From Delta

I'm seeing some attractive plays among the airlines.

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

Always, always, always stick to your rules. Always. This is why we have targets, pivots and panics.

Bitcoin Stabilizes, COVID Update, Earnings So Far, Apple Event

Bitcoin Stabilizes, COVID Update, Earnings So Far, Apple Event

The marketplace responded well to the first week of earnings season, or should we say what we saw beyond the banks that dominated.

Tricky Technical Conditions Persist as Substantial News Flow Starts to Hit

Tricky Technical Conditions Persist as Substantial News Flow Starts to Hit

It's easy to be caught on the wrong side of the rotations if you aren't careful.

Jim Cramer: We've Got a Boom ... and a Bust

Jim Cramer: We've Got a Boom ... and a Bust

Let's look at this impossible move on the market -- and why health care could be coming off life support.

The Reflex Game, Re-Rotation, Big Bank Bonanza, Oil Demand, Johnson & Johnson

The Reflex Game, Re-Rotation, Big Bank Bonanza, Oil Demand, Johnson & Johnson

How Interesting. On Wednesday, market participants rotated out of the un-rotation that had been in vogue for most of April.

Jim Cramer: All This 'Speculative Mania' Is Just a Well-Contained Sideshow

Jim Cramer: All This 'Speculative Mania' Is Just a Well-Contained Sideshow

Bitcoin, NFTs, ethereum or even the S&P are not what matters right now. They're simply a series of exciting developments that aren't putting people to work.

Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase

Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase

Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.

American Airlines Still Has a Ticket to the Reopening

American Airlines Still Has a Ticket to the Reopening

Here's how to play AAL as it's off because of vaccine news.

Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job

Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job

You never want to be caught in a counter trend rally.

Jim Cramer: Here's Why I Pulled $100,000 From the Market

Jim Cramer: Here's Why I Pulled $100,000 From the Market

These seven concerns are why I took money out of the market for my charitable trust.

The Data Mattas

The March CPI rose +0.6% month over month and +0.3% ex food and energy, both one tenth more than expected. These can't be explained away by easy comps. The easy comps are year over year where the headline increase was +2.6% and the core rate rose by...

I'm Not Bailing on Johnson & Johnson Now

I'm Not Bailing on Johnson & Johnson Now

Don't forget, this is a very large company with a lot more than the vaccine going on.